ReviewHereditary cancer in clinical practice2017

Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.

B Meiser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.